Gene · 55143
Papers1,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antimicrobial cyclic peptides effectively inhibit multiple forms of Borrelia and cross the blood-brain barrier model. | Sci Rep | 2025 | 39979461 | PubTator, text mining | PubMed |
| Promyelocytic Leukemia Protein (PML) Regulates Stem Cell Pluripotency Through Novel Sumoylation Targets. | Int J Mol Sci | 2025 | 39940913 | PubTator, text mining | PubMed |
| CDCA genes as prognostic and therapeutic targets in Colon adenocarcinoma. | Hereditas | 2025 | 39924497 | PubTator, text mining | PubMed |
| Roles of the CDCA gene family in breast carcinoma. | Sci Prog | 2025 | 39814554 | PubTator, text mining | PubMed |
| The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO. | Cancer Rep (Hoboken) | 2025 | 39764737 | PubTator, text mining | PubMed |
| Aneuploidy-driven gene expression profiling in human blastocysts: insights from RNA-Seq analysis. | J Assist Reprod Genet | 2025 | 39753942 | PubTator, text mining | PubMed |
| Deciphering the prognostic landscape of triple-negative breast cancer: A focus on immune-related hub genes and therapeutic implications. | Biotechnol Appl Biochem | 2025 | 39587411 | PubTator, text mining | PubMed |
| Molecular and mechanical mechanisms of animal cell abscission. | FEBS Lett | 2025 | 39324548 | PubTator, text mining | PubMed |
| Identifying ribonucleotide reductase subunit genes as potential lung adenocarcinomas biomarkers using integrated bioinformatics analysis. | Malawi Med J | 2024 | 40191558 | PubTator, text mining | PubMed |
| MiR-490-3p promotes cell apoptosis and cell-cycle arrest in osteosarcoma via the modulation of CDCA8/ATF3 by targeting NUSAP1. | Transl Pediatr | 2024 | 39823004 | PubTator, text mining | PubMed |
| The landscape in telomere related gene prognostic signature for survival and medication treatment effectiveness prediction in hepatocellular carcinoma. | Discov Oncol | 2024 | 39692822 | PubTator, text mining | PubMed |
| Interspecies transcriptome profiles of human T cell activation and liver inflammation in a xenogeneic graft-versus-host disease model. | Heliyon | 2024 | 39687194 | PubTator, text mining | PubMed |
| Shared and specific competing endogenous RNAs network mining in four digestive system tumors. | Comput Struct Biotechnol J | 2024 | 39669749 | PubTator, text mining | PubMed |
| CRISPR-Cas9 screening identified novel subtypes of cutaneous melanoma based on essential cancer genes. | Arch Dermatol Res | 2024 | 39644349 | PubTator, text mining | PubMed |
| Deciphering molecular landscape of breast cancer progression and insights from functional genomics and therapeutic explorations followed by in vitro validation. | Sci Rep | 2024 | 39567714 | PubTator, text mining | PubMed |
| Identification of alternative lengthening of telomeres-related genes prognosis model in hepatocellular carcinoma. | BMC Cancer | 2024 | 39529015 | PubTator, text mining | PubMed |
| Discovery of key molecular signatures for diagnosis and therapies of glioblastoma by combining supervised and unsupervised learning approaches. | Sci Rep | 2024 | 39528802 | PubTator, text mining | PubMed |
| Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma. | BMC Med Genomics | 2024 | 39516785 | PubTator, text mining | PubMed |
| Old Passengers as New Drivers: Chromosomal Passenger Proteins Engage in Translesion Synthesis. | Cells | 2024 | 39513910 | PubTator, text mining | PubMed |
| The Chromosome Passenger Complex (CPC) Components and Its Associated Pathways Are Promising Candidates to Differentiate Between Normosensitive and Radiosensitive ATM-Mutated Cells. | Biomark Insights | 2024 | 39493730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55143/papers?page=4